Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

被引：0
|
作者：
Yoshida, N. [1 ]
Yabe, H. [2 ]
Kudo, K. [3 ]
Kobayashi, R. [4 ]
Yabe, M. [2 ]
Inoue, M. [5 ,6 ]
Miki, M. [7 ]
Sakamaki, H. [8 ]
Kawa, K. [9 ]
Suzuki, R. [10 ]
Kato, K. [1 ]
Watanabe, K. -I. [11 ]
Kojima, S. [12 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[2] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan
[4] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan
[5] Osaka Med Ctr, Dept Hematol Oncol, Izumi, Japan
[6] Res Inst Maternal & Child Hlth, Izumi, Japan
[7] Hiroshima Univ, Dept Pediat, Grad Sch Biomed Sci, Hiroshima, Japan
[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan
[9] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Japan
[10] Nagoya Univ, Dept HSCT Data Management & Biostat, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[11] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan
[12] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O151
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [41] Feasibility of Second Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning with Fludarabine and Melphalan after a Failed Autologous Hematopoietic Stem Cell Transplantation
    Hong, J. Y.
    Choi, M. K.
    Kim, D. H.
    Kim, S. J.
    Kim, K.
    Kim, W. S.
    Chung, C. W.
    Kim, H. O.
    Min, Y. H.
    Jang, J. H.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3723 - 3728
  • [42] Fludarabine in combination with melphalan and ATG can be the best conditioning for hematopoietic stem cell transplant of children with hemophagocytic lymphohistiocytosis
    Mehdiabadi, Gholamreza Bahoush
    BONE MARROW TRANSPLANTATION, 2019, 54 : 227 - 227
  • [43] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [44] Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group
    Chen, Jing
    Lee, Vincent
    Luo, Cheng Juan
    Chiang, Alan Kwok Shing
    Hongeng, Suradej
    Tan, Poh Lin
    Tan, Ah Moy
    Sanpakit, Kleebsabai
    Li, Chun Fu
    Lee, Anselm Chi-wai
    Chua, Hsin Chieh
    Okamoto, Yasuhiro
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (03) : 383 - 391
  • [45] Haematopoietic stem cell transplantation in children with bone marrow failure: a single-centre experience
    Kupesiz, A.
    Karasu, G. Tezcan
    Uygun, V.
    Kurt, P.
    Ozturk, Z.
    Kazik, M.
    Hazar, V.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S184 - S184
  • [46] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [47] Alternative donor stem cell transplantation after reduced intensity conditioning regimen for patients with bone marrow failure
    Kabbara, N
    Rocha, V
    Robin, M
    Devergie, A
    Ribaud, P
    Socie, G
    Gluckman, E
    Esperou, H
    BLOOD, 2005, 106 (11) : 811A - 812A
  • [48] Fludarabine and low dose of melphalan as effective conditioning regimen for allogeneic stem cell transplantation in lymphoproliferative diseases and multiple myeloma
    Yanez, L.
    Bermudez, A.
    Perez, G.
    Diez, Z.
    Richard, C.
    Iriondo, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S404 - S405
  • [49] Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan
    Miharu Yabe
    Yoshitoshi Ohtsuka
    Kenichiro Watanabe
    Jiro Inagaki
    Nao Yoshida
    Kazuo Sakashita
    Harumi Kakuda
    Hiromasa Yabe
    Hidemitsu Kurosawa
    Kazuko Kudo
    Atsushi Manabe
    International Journal of Hematology, 2015, 101 : 184 - 190
  • [50] Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
    Nishimura, Akira
    Aoki, Yuki
    Ishiwata, Yasuyoshi
    Ichimura, Takuya
    Ueyama, Junichi
    Kawahara, Yuta
    Tomoda, Takahiro
    Inoue, Maiko
    Matsumoto, Kazuaki
    Inoue, Kento
    Hiroki, Haruka
    Ono, Shintaro
    Yamashita, Motoi
    Okano, Tsubasa
    Tanaka-Kubota, Mari
    Ashiarai, Miho
    Miyamoto, Satoshi
    Miyawaki, Reiji
    Yamagishi, Chika
    Tezuka, Mari
    Okawa, Teppei
    Hoshino, Akihiro
    Endo, Akifumi
    Yasuhara, Masato
    Kamiya, Takahiro
    Mitsuiki, Noriko
    Ono, Toshiaki
    Isoda, Takeshi
    Yanagimachi, Masakatsu
    Tomizawa, Daisuke
    Nagasawa, Masayuki
    Mizutani, Shuki
    Kajiwara, Michiko
    Takagi, Masatoshi
    Kanegane, Hirokazu
    Imai, Kohsuke
    Morio, Tomohiro
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (05) : 944 - 957
12345